| Joseph J Corning, MD | |
|
420 Saybrook Rd, Middlesex Cardiology Associates, Middletown, CT 06457-4747 | |
| (860) 347-4258 | |
| (860) 704-5924 |
| Full Name | Joseph J Corning |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 420 Saybrook Rd, Middletown, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669580569 | NPI | - | NPPES |
| 744834 | Other | CT | |
| 010028525CT04 | Other | ANTHEM | |
| 060039541 | Other | OXFORD | |
| 0V1638 | Other | HEALTH NET | |
| 0000214715301 | Other | UNITED HC | |
| 00128525500 | Other | EDS BLUE CARE | |
| 0521206003 | Other | CIGNA | |
| 2104942 | Other | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 028525 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Middlesex Hospital | Middletown, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
Three key technologies, identified in the pre-budget statement by The Chancellor of the Exchequer as part of the government's 'eight great technologies' to drive UK growth, are to receive an -85 million investment for capital equipment.
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
According to a report by the World Health Organization (WHO) inequities around the world are responsible for killing people on a "grand scale".
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
› Verified 9 days ago
| Entity Name | Hartford Healthcare Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043561301 PECOS PAC ID: 1153573902 Enrollment ID: O20121201000007 |
News Archive
Three key technologies, identified in the pre-budget statement by The Chancellor of the Exchequer as part of the government's 'eight great technologies' to drive UK growth, are to receive an -85 million investment for capital equipment.
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
According to a report by the World Health Organization (WHO) inequities around the world are responsible for killing people on a "grand scale".
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
› Verified 9 days ago
| Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Three key technologies, identified in the pre-budget statement by The Chancellor of the Exchequer as part of the government's 'eight great technologies' to drive UK growth, are to receive an -85 million investment for capital equipment.
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
According to a report by the World Health Organization (WHO) inequities around the world are responsible for killing people on a "grand scale".
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph J Corning, MD 420 Saybrook Rd, Ste A, Middletown, CT 06457-4747 Ph: (860) 636-2010 | Joseph J Corning, MD 420 Saybrook Rd, Middlesex Cardiology Associates, Middletown, CT 06457-4747 Ph: (860) 347-4258 |
News Archive
Three key technologies, identified in the pre-budget statement by The Chancellor of the Exchequer as part of the government's 'eight great technologies' to drive UK growth, are to receive an -85 million investment for capital equipment.
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
According to a report by the World Health Organization (WHO) inequities around the world are responsible for killing people on a "grand scale".
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
NuVasive, Inc., a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that United Healthcare changed its lumbar spinal fusion policy to include coverage for the eXtreme Lateral Interbody Fusion, or XLIF procedure, published on February 26, 2010, a reversal from its previous policy that labeled XLIF as unproven.
› Verified 9 days ago
Dr. Miklos C. Fogarasi, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 | |
George Agyapong, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Silver Street, Middletown, CT 06457 Phone: 860-262-5128 | |
Lisa Ochola-tinker, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 28 Crescent St, Middletown, CT 06457 Phone: 860-358-5322 Fax: 860-358-6298 | |
Dr. James Kar-kee Yue, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 760 Saybrook Rd, Middletown, CT 06457 Phone: 860-347-3304 Fax: 860-346-8245 | |
Mario Q Ricci Jr., MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 410 Saybrook Rd, Suite 201, Middletown, CT 06457 Phone: 860-347-4620 Fax: 860-346-9687 | |
Dr. Crispin Reynaldo Abarientos, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 80 S Main St, Middletown, CT 06457 Phone: 860-358-6878 Fax: 860-358-6870 | |
Stephen M Franklin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 420 Saybrook Rd, Middlesex Cardiology Associates, Middletown, CT 06457 Phone: 860-347-4258 Fax: 860-704-5924 |